TPCW
IDXX icon

TD Private Client Wealth’s Idexx Laboratories IDXX Stock Holding History

TD Private Client Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$258K Buy
490
+326
+199% +$183K ﹤0.01% 623
2026
Q1 		$92.2K Sell
164
-126
-43% -$80.8K ﹤0.01% 772
2025
Q4 		$196K Sell
290
-76
-21% -$51.8K ﹤0.01% 662
2025
Q3 		$234K Buy
366
+141
+63% +$85.6K 0.01% 628
2025
Q2 		$121K Buy
225
+82
+57% +$39.2K ﹤0.01% 714
2025
Q1 		$60.1K Sell
143
-349
-71% -$152K ﹤0.01% 779
2024
Q4 		$203K Sell
492
-2,226
-82% -$976K 0.01% 598
2024
Q3 		$1.37M Sell
2,718
-953
-26% -$463K 0.04% 314
2024
Q2 		$1.79M Sell
3,671
-132
-3% -$66.3K 0.06% 253
2024
Q1 		$2.05M Sell
3,803
-137
-3% -$74.9K 0.07% 232
2023
Q4 		$2.19M Buy
3,940
+1,187
+43% +$557K 0.08% 203
2023
Q3 		$1.2M Sell
2,753
-108
-4% -$53.9K 0.05% 293
2023
Q2 		$1.44M Sell
2,861
-121
-4% -$58K 0.06% 275
2023
Q1 		$1.49M Sell
2,982
-93
-3% -$44.5K 0.07% 268
2022
Q4 		$1.25M Sell
3,075
-14
-0.5% -$5.43K 0.06% 286
2022
Q3 		$1.01M Sell
3,089
-221
-7% -$81.2K 0.05% 309
2022
Q2 		$1.16M Sell
3,310
-215
-6% -$87.7K 0.06% 292
2022
Q1 		$1.93M Buy
3,525
+355
+11% +$187K 0.08% 240
2021
Q4 		$2.09M Buy
3,170
+109
+4% +$68.4K 0.09% 230
2021
Q3 		$1.9M Sell
3,061
-254
-8% -$171K 0.08% 243
2021
Q2 		$2.09M Buy
3,315
+98
+3% +$54.1K 0.09% 228
2021
Q1 		$1.57M Buy
3,217
+77
+2% +$38.6K 0.07% 267
2020
Q4 		$1.57M Buy
3,140
+239
+8% +$107K 0.08% 249
2020
Q3 		$1.14M Sell
2,901
-245
-8% -$90.6K 0.06% 270
2020
Q2 		$1.04M Buy
3,146
+1,356
+76% +$393K 0.06% 277
2020
Q1 		$434K Buy
1,790
+278
+18% +$72.5K 0.03% 342
2019
Q4 		$395K Buy
+1,512
New +$398K 0.02% 385

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

TD Private Client Wealth's IDXX Position: Q2 2026 in Review

TD Private Client Wealth increased its Idexx Laboratories (IDXX) stake by 199% in Q2 2026, buying an estimated $183K and bringing the position to 490 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #623.

TD Private Client Wealth first reported a position in IDXX in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.19M in Q4 2023. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • TD Private Client Wealth held 490 shares of Idexx Laboratories worth $258K as of Q2 2026.
  • TD Private Client Wealth bought 326 Idexx Laboratories shares in Q2 2026, an estimated $183K.
  • Idexx Laboratories made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #623 holding.
  • TD Private Client Wealth first reported a position in Idexx Laboratories in Q4 2019 and has held it in 27 quarters since.
  • TD Private Client Wealth's Idexx Laboratories position peaked at $2.19M in Q4 2023.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.